Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.
3.
4.

[Laparoscopic and general surgery guided by open interventional magnetic resonance].

Lauro A, Gould SW, Cirocchi R, Giustozzi G, Darzi A.

Minerva Chir. 2004 Oct;59(5):507-16. Italian.

PMID:
15494679
5.

Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.

Paciorek CJ, Liu Y; HEI Health Review Committee.

Res Rep Health Eff Inst. 2012 May;(167):5-83; discussion 85-91.

PMID:
22838153
6.

Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.

Cabioglu N, Hunt KK, Sahin AA, Kuerer HM, Babiera GV, Singletary SE, Whitman GJ, Ross MI, Ames FC, Feig BW, Buchholz TA, Meric-Bernstam F.

Ann Surg Oncol. 2007 Apr;14(4):1458-71. Epub 2007 Jan 28.

PMID:
17260108
8.

[Magnetic resonance imaging in preoperative staging for breast cancer: pros and contras].

Kuhl CK, Braun M.

Radiologe. 2008 Apr;48(4):358-66. doi: 10.1007/s00117-008-1665-2. Review. German.

PMID:
18369582
9.

Cost-benefit analysis of using large-format histology sections in routine diagnostic breast care.

Tot T.

Breast. 2010 Aug;19(4):284-8. doi: 10.1016/j.breast.2010.03.015. Epub 2010 Apr 10. Review.

PMID:
20382020
10.

The evaluation of the data collection process for a multicenter, population-based, case-control design.

Wingo PA, Ory HW, Layde PM, Lee NC.

Am J Epidemiol. 1988 Jul;128(1):206-17.

PMID:
3381827
11.
12.
13.

Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.

Solin LJ, McCormick B, Recht A, Haffty BG, Taylor ME, Kuske RR, Bornstein BA, McNeese M, Schultz DJ, Fowble BL, Barrett W, Yeh IT, Kurtz JM, Amalric R, Fourquet A.

Cancer J Sci Am. 1996 May-Jun;2(3):158-65.

PMID:
9166516
14.

Clinically relevant breast cancer reporting: using process measures to improve anatomic pathology reporting.

Hammond EH, Flinner RL.

Arch Pathol Lab Med. 1997 Nov;121(11):1171-5.

PMID:
9372744
15.

Impact of breast MRI on surgical treatment, axillary approach, and systemic therapy for breast cancer.

Mameri CS, Kemp C, Goldman SM, Sobral LA, Ajzen S.

Breast J. 2008 May-Jun;14(3):236-44. doi: 10.1111/j.1524-4741.2008.00568.x.

PMID:
18476882
16.

Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.

Wallace AM, Daniel BL, Jeffrey SS, Birdwell RL, Nowels KW, Dirbas FM, Schraedley-Desmond P, Ikeda DM.

J Am Coll Surg. 2005 Apr;200(4):527-37.

PMID:
15804466
17.

Detection with MR imaging of residual tumor in the breast soon after surgery.

Soderstrom CE, Harms SE, Farrell RS Jr, Pruneda JM, Flamig DP.

AJR Am J Roentgenol. 1997 Feb;168(2):485-8.

PMID:
9016232
18.

Tumor size on abdominal MRI versus pathologic specimen in resected pancreatic adenocarcinoma: implications for radiation treatment planning.

Hall WA, Mikell JL, Mittal P, Colbert L, Prabhu RS, Kooby DA, Nickleach D, Hanley K, Sarmiento JM, Ali AN, Landry JC.

Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):102-7. doi: 10.1016/j.ijrobp.2012.11.019. Epub 2013 Jan 3.

PMID:
23290442
19.

MRI for surgical planning in patients with breast cancer who undergo preoperative chemotherapy.

Thibault F, Nos C, Meunier M, El Khoury C, Ollivier L, Sigal-Zafrani B, Clough K; Institut Curie Breast Cancer Group.

AJR Am J Roentgenol. 2004 Oct;183(4):1159-68.

PMID:
15385323
20.

Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.

Kuerer HM, Newman LA, Buzdar AU, Dhingra K, Hunt KK, Buchholz TA, Binkley SM, Strom EA, Ames FC, Ross MI, Feig BW, McNeese MD, Hortobagyi GN, Singletary SE.

Cancer J Sci Am. 1998 Jul-Aug;4(4):230-6.

PMID:
9689981

Supplemental Content

Support Center